AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company is developing epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize, or otherwise exploit certain compounds and products, including epetraborole, for the treatment, diagnosis, or prevention of all human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize certain compounds and products, including epetraborole, in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/30/2026 13:20 PDT] AN2 Therapeutics, Inc. (NASDAQ:ANTX), Up By 100% ($4.37) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, July 8th 2026 at a Price of $4.37.
• [07/14/2026 06:55 PDT] ANTX Expected to Trade Up After Bullish Patterns Develop
• [07/08/2026 11:07 PDT] ANTX SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/23/2026 13:58 PDT] AN2 Therapeutics, Inc. (NASDAQ:ANTX), Up By 100% ($4.45) From $4.45 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [06/15/2026 11:07 PDT] AN2 Therapeutics, Inc. (NASDAQ:ANTX), Up By 100% ($3.91) From $3.91 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [06/12/2026 08:02 PDT] ANTX Expected to Trade Up After Bullish Patterns Develop
• [06/11/2026 10:29 PDT] ANTX SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/11/2026 10:29 PDT] AN2 Therapeutics, Inc. (NASDAQ:ANTX), Up By 100% ($3.66) From $3.66 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [06/10/2026 07:17 PDT] ANTX Expected to Trade Up After Bullish Patterns Develop
• [06/09/2026 07:11 PDT] ANTX Expected to Trade Up After Bullish Patterns Develop
• [06/04/2026 10:29 PDT] ANTX SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/03/2026 07:24 PDT] ANTX Expected to Trade Down After Bearish Patterns Develop